The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects
Hidekazu Itamura(Saga University), Shinya Kimura(Saga University)
Cited by 26
Related Papers
2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent
|PLoS ONE|2015|77
The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
|Oncotarget|2016|13